Table 2.
Volumetric Assessment of Vascular Geometry and Progression of Allograft Vasculopathy During Follow-Up in patients with DSA II+ vs. DSA−
DSA II+ (n = 11) | DSA− (n=34) | P Value | |
---|---|---|---|
Vessel Volume/Segment Length | |||
Baseline (mm3/mm) | 14.7±4 | 14.9±4 | 0.75# |
2ND IVUS (mm3/mm) | 14.2±5 | 15.7±4 | 0.48# |
Absolute difference (mm3/mm) | −0.51±3 | +0.81±4 | 0.3* |
Change in % | −9.6±25 | +1.3±3 | 0.2* |
P-value | 0.6¶ | 0.3¶ | |
Plaque Volume/Segment Length | |||
Baseline (mm3/mm) | 3.6±1 | 4.8±2 | 0.2# |
2 ND IVUS (mm3/mm) | 4.0±2 | 4.9±2 | 0.25# |
Absolute difference (mm3/mm) | +0.51±1 | +0.06±1 | 0.42* |
Change in % | +6.2±22 | −5.4±24 | 0.5* |
P-value | 0.1¶ | 0.8¶ | |
Plaque index | |||
Baseline (mm3) | 0.24±0.06 | 0.31±0.1 | 0.02# |
2 ND IVUS (mm3) | 0.27±0.07 | 0.31±0.11 | 0.40# |
Absolute difference (mm3) | +0.04±0.03 | −0.003±0.07 | 0.05* |
Change in % | +13.8±12 | −7.9±18 | 0.02* |
P-value | 0.01¶ | 0.8¶ |
SL: segment length; VV: vessel volume; LV: lumen volume; PV: plaque volume; PI: plaque index.
ANCOVA test; baseline value is a covariate.
Paired t test
t test